MESO
Price
$10.62
Change
+$0.23 (+2.22%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.32B
85 days until earnings call
TNGX
Price
$3.24
Change
+$0.70 (+27.56%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
351.2M
64 days until earnings call
Interact to see
Advertisement

MESO vs TNGX

Header iconMESO vs TNGX Comparison
Open Charts MESO vs TNGXBanner chart's image
Mesoblast
Price$10.62
Change+$0.23 (+2.22%)
Volume$1.21K
Capitalization1.32B
Tango Therapeutics
Price$3.24
Change+$0.70 (+27.56%)
Volume$59.21K
Capitalization351.2M
MESO vs TNGX Comparison Chart
Loading...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. TNGX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Buy and TNGX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (MESO: $10.55 vs. TNGX: $3.24)
Brand notoriety: MESO and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 59% vs. TNGX: 517%
Market capitalization -- MESO: $1.32B vs. TNGX: $351.2M
MESO [@Biotechnology] is valued at $1.32B. TNGX’s [@Biotechnology] market capitalization is $351.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, TNGX is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TNGX’s TA Score shows that 5 TA indicator(s) are bullish.

  • TNGX’s TA Score: 5 bullish, 4 bearish.

Price Growth

MESO (@Biotechnology) experienced а -3.83% price change this week, while TNGX (@Biotechnology) price change was +58.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

TNGX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.32B) has a higher market cap than TNGX($351M). TNGX YTD gains are higher at: -17.799 vs. MESO (-47.576). MESO has higher annual earnings (EBITDA): -77.78M vs. TNGX (-143.1M). TNGX has more cash in the bank: 258M vs. MESO (37.7M). TNGX has less debt than MESO: TNGX (36.5M) vs MESO (126M). TNGX has higher revenues than MESO: TNGX (42.1M) vs MESO (5.67M).
MESOTNGXMESO / TNGX
Capitalization1.32B351M376%
EBITDA-77.78M-143.1M54%
Gain YTD-47.576-17.799267%
P/E RatioN/AN/A-
Revenue5.67M42.1M13%
Total Cash37.7M258M15%
Total Debt126M36.5M345%
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APLIX11.63N/A
N/A
Cavanal Hill Hedged Equity Income Inv
ACCLX15.30N/A
N/A
American Century Mid Cap Value C
FMCVX23.72N/A
N/A
Franklin Mutual Small-Mid Cap Val R6
USRAX31.33N/A
N/A
Horizon Multi-Factor U.S. Equity Inv
NRAEX49.97N/A
N/A
Neuberger Berman Sustainable Equity E

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been closely correlated with SAGE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MESO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-2.44%
SAGE - MESO
66%
Closely correlated
+2.48%
QTTB - MESO
51%
Loosely correlated
+5.78%
TNGX - MESO
33%
Poorly correlated
+14.41%
AVTX - MESO
32%
Poorly correlated
+8.75%
ZURA - MESO
31%
Poorly correlated
N/A
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+14.41%
AXON - TNGX
41%
Loosely correlated
+1.09%
IMTX - TNGX
39%
Loosely correlated
+11.50%
MDGL - TNGX
39%
Loosely correlated
-0.94%
ITOS - TNGX
37%
Loosely correlated
-0.10%
BNTC - TNGX
36%
Loosely correlated
+1.63%
More